CD44 Cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (αLβ2) and VLA-4 (α4β1)

[1]  C. Isidoro,et al.  Preconditioning-induced cytoprotection in hepatocytes requires Ca2+-dependent exocytosis of lysosomes , 2004, Journal of Cell Science.

[2]  J. Sleeman,et al.  CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. , 2001, Journal of cell science.

[3]  Ke Xiong,et al.  Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA‐4 in addition to LFA‐1 , 2001, Journal of leukocyte biology.

[4]  T. Irimura,et al.  CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. , 1999, Cancer research.

[5]  S. Jothy,et al.  CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. , 1999, Experimental and molecular pathology.

[6]  K. Fujii,et al.  Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. , 1999, Journal of immunology.

[7]  T. Nordström,et al.  The Role of α2β1 and α3β1 Integrin Receptors in the Initial Anchoring of MDA-MB-231 Human Breast Cancer Cells to Cortical Bone Matrix , 1998 .

[8]  K. Selmaj,et al.  Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down‐regulation of VCAM‐1/VLA‐4 , 1998, European journal of immunology.

[9]  Martin R. Schneider,et al.  Negative Cooperativity between α3β1and α2β1Integrins in Human Mammary Carcinoma MDA MB 231 Cells , 1998 .

[10]  T. Meyer,et al.  Expression of alphav integrins and vitronectin receptor identity in breast cancer cells. , 1998, British Journal of Cancer.

[11]  S. Eto,et al.  Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription. , 1996, Journal of immunology.

[12]  E. A. Price,et al.  beta-1 Integrins mediate tumour cell adhesion to quiescent endothelial cells in vitro. , 1996, British Journal of Cancer.

[13]  N. Hogg,et al.  T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1. , 1996, Journal of immunology.

[14]  G. Vinson,et al.  In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix , 1995, The British journal of surgery.

[15]  M. Zahalka,et al.  Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. , 1995, Journal of immunology.

[16]  L. Bourguignon,et al.  New CD44 splice variants associated with human breast cancers , 1995, Journal of cellular physiology.

[17]  C. Figdor,et al.  Distinct binding of T lymphocytes to ICAM‐1, ‐2 or ‐3 upon activation of LFA‐1 , 1994, European journal of immunology.

[18]  M. Culty,et al.  Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential , 1994, Journal of cellular physiology.

[19]  M. Zahalka,et al.  Beta 2-integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness. , 1994, International Immunology.

[20]  J. Narula,et al.  Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. , 1994, Cancer research.

[21]  P. Herrlich,et al.  Prevention of tumor metastasis formation by anti-variant CD44 , 1993, The Journal of experimental medicine.

[22]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Underhill,et al.  CD44: the hyaluronan receptor. , 1992, Journal of cell science.

[24]  Y. Tanaka,et al.  CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion , 1992, The Journal of experimental medicine.

[25]  J. Greve,et al.  Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor. , 1992, The American journal of pathology.

[26]  R. Kannagi,et al.  Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. , 1991, Biochemical and biophysical research communications.

[27]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[28]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[29]  G. Rice,et al.  Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism , 1990, The Journal of experimental medicine.

[30]  P. Epstein,et al.  Calmodulin dependence of transferrin receptor recycling in rat reticulocytes. , 1990, The Biochemical journal.

[31]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[32]  G. Rice,et al.  An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. , 1989, Science.

[33]  L. Wahl,et al.  Dual role of the CD44 molecule in T cell adhesion and activation. , 1989, Journal of immunology.

[34]  R. Wilson,et al.  Molecular aspects of the metastatic cascade. , 1989, Biochimica et biophysica acta.

[35]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[36]  H. Kohno,et al.  Transferrin and iron uptake by rat reticulocytes. , 1985, Journal of biochemistry.

[37]  Ronit Vogt Sionov,et al.  CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.

[38]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[39]  R. Pardi,et al.  Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. , 1992, Immunology today.

[40]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.